/Passle/67292836ee4aa642c0980b65/SearchServiceImages/2025-11-11-13-37-58-170-69133c363071ba9adf659979.jpg)
The Centers for Medicare & Medicaid Services (“CMS”) announced preliminary Medicare Part D bid parameters for year 2026 to help plan...
Reed Smith LLP
In the final 2025 Medicare Physician Fee Schedule, which is set to be published in the Federal Register on December 9, the Centers for...
On April 8, 2024, the Department of Health and Human Services Office of Inspector General (OIG) issued Advisory Opinion No. 24-02,...
Making good on its promises to enhance oversight of Medicare Advantage (MA) and Medicare Part D plans, the Centers for Medicare and...
On Nov. 8, 2023, the Senate Finance Committee voted 26-0 to approve the Better Mental Health, Lower Cost Drugs, and Extenders Act. Among...
As the September 1, 2023 deadline for Centers for Medicare & Medicaid Services (CMS) to publish the first 10 “selected drugs” subject to...
On December 28, 2022, the Department of Health and Human Services’ Office of Inspector General (OIG) issued a favorable advisory opinion...
The Inflation Reduction Act included some very significant changes to the ways in which the Medicare program handles drug pricing. Among...
The Centers for Medicare and Medicaid Services has published a final rule that governed the way that Medicare Advantage and Medicare Part...
In November 2020, four months after the Trump Administration issued a series of Executive Orders reiterating its policy goals on reducing...
The Centers for Medicare and Medicaid Services (CMS) has announced a new voluntary Part D Senior Savings Model (the Model) intended to...
CMS has put on display a proposed rule that would update Medicare Advantage (MA) and Medicare Part D prescription drug benefit policies...